InsiderTrades

Form 4 for BMY Bristol Myers Squibb

Accepted 2025-11-04 00:00:00 ET · period of report 2025-11-01 · accession 0001917325-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-11-04 2025-11-01 BMY Shanahan Karin EVP, Chief Supply Chain, Ops M - OptEx $0.00 +6,281 20.1K +46% $0
D 2025-11-04 2025-11-01 BMY Shanahan Karin EVP, Chief Supply Chain, Ops F - Tax $46.07 -3,213 16.9K -16% -$148.0K
D 2025-11-04 2025-11-01 BMY Shanahan Karin EVP, Chief Supply Chain, Ops M - OptEx $0.00 -6,281 12.6K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.10 par value 2025-11-01 M A 6,281 $0.00 20,078 D — — (F1) Represents vesting of one-third of restricted stock units granted on November 1, 2024.
2 Common Common Stock, $0.10 par value 2025-11-01 F D 3,213 $46.07 16,865 D — — (F2) Shares withheld for payment of taxes upon vesting of awards.
3 Derivative Restricted Stock Units 2025-11-01 M D 6,281 $0.00 12,562 D — · — to 2027-11-01 6,281 Common Stock, $0.10 par value (F4) Each restricted stock unit converts into one share of common stock upon vesting. (F5) The restricted stock units vest in three equal annual installments beginning on November 1, 2025.